Two values that are close to our hearts and central to our quality policy

Who we are ?

EYLIO is founded in 2019, focusing on advising and supporting biotech companies from the discovery of a molecule of interest through to the end of clinical trials.
‍
From the outset, EYLIO provide external audits and batch release services for marketing authorization and clinical batches worldwide. Thanks to this experience, EYLIO has identified a growing need for auditing, testing, certification, support and consultancy services in all areas of healthcare. As a result, EYLIO's offer is gradually expanding. 
‍
Recently established at the heart of the Illkirch-Graffenstaden biopole, center of excellence for biotech companies and for the Alsace ecosystem as a whole, EYLIO aims to become a multi-service platform in the coming years.

Our most ambitious project is the commissioning of a 200m² GMP-compliant production area totally dedicated to the production and packaging of drugs from pre-clinical phase to phase II, with the creation of a quality control laboratory.

EYLIO thus offers a turnkey solution in Alsace for all the actors in the biotech world. We are a complete partner in the realization of your most ambitious projects, from analytical development to the storage of the most sensitive products (up to -80°), including their release and import.